From Formulation To Global Supply: Mastering Oral Solid Development

Oral solid dosage forms remain central to modern pharmaceuticals, yet global development and scale‑up require tight coordination across all stages. Integrated development models support oral solid programs from early formulation through commercial manufacturing.

Early‑stage activities such as preformulation, API characterization, and prototype optimization are combined with advanced processing technologies, including granulation, spray drying, hot‑melt extrusion, and emerging 3D printing applications. These capabilities enable systematic solutions to challenges including poor solubility, taste masking, modified release, and patient‑centric dosing.

Alignment between development and manufacturing sites streamlines technology transfer, accelerates clinical supply, and reduces late‑stage technical and regulatory risk. Manufacturing readiness for launch—supported by validated processes, adaptable capacity, and resilient supply chains—ensures continuity into commercialization. Coordinated integration across formulation science, enabling technologies, and manufacturing execution supports efficient scale‑up and consistent delivery for global markets.